Expert consensus on breast cancer targeted therapy with subcutaneous injection
10.3761/j.issn.0254-1769.2025.01.006
- VernacularTitle:乳腺癌靶向药物皮下注射护理专家共识
- Author:
Liying WANG
;
Huiying QIN
;
Yuhan LU
;
Jiajia QIU
;
Zhenqi LU
- Collective Name:Cancer Nursing Committee of Chinese Nursing Association;Cancer Nursing Committee of Shanghai Anti-Cancer Association
- Publication Type:Journal Article
- Keywords:
Trastuzumab;
Pertuzumab;
Injections,Subcutaneous;
Breast Cancer;
Expert Consensus;
Nursing Care
- From:
Chinese Journal of Nursing
2025;60(1):43-47
- CountryChina
- Language:Chinese
-
Abstract:
Objective To develop an expert consensus on the subcutaneous injection of targeted drugs for breast cancer,to guide clinical nursing practice.Methods A consensus building group was established to create the initial draft of the consensus based on a review of literature.From December 2023 to February 2024,a total of 84 experts from various fields including breast cancer clinical nursing or medical practice,pharmacology,cancer hospital nursing or medical management were invited to participate in 2 rounds of expert letter consultations.Additionally,an on-site expert discussion meeting and an online expert finalization meeting were conducted to finalize the draft"consensus".Results The finalized consensus includes sections covering basic drug introduction,drug injection nursing(injection personnel,injection preparation,injection points,observation and recording after injection),nursing care for adverse reactions,patient education and follow-up.Conclusion This consensus is scientific and practical.It can serve as a valuable reference for clinical practice related to subcutaneous therapy using targeted drugs for breast cancer.
